"According to the latest report published by Data Bridge Market Research, the  Dual GIP/ GLP-1 Receptor Agonists Obesity Drugs Market  CAGR Value The global dual GIP/ GLP-1 receptor agonists obesity drugs market size was valued at USD 4.75 billion in 2024 and is expected to reach USD 17.71 billion by 2032, at a CAGR of 17.85% during the forecast period This world-wide Dual...